Sree Rayalaseema Hi-Strength Hypo Limited
SRHHYPOLTD · NSE · Basic Materials
With a 20% margin of safety, our buy-below price is ₹796.24. Low-confidence estimate — limited data.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%9.4%
- ✓Low debt (D/E < 0.5)0.01x
- ✓Positive free cash flow
- ✕Revenue growth > 10%2%
- ✕Earnings growing-17%
- ✓Net margin ≥ 10%13.5%
- ✓Current ratio > 1.510.55
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 5.93
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-16Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 5.93.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Trading in our value buy zone versus sector peers.
- •Trades ~100% below our estimated fair value.
Threats
- •Earnings contracting year on year.
About Sree Rayalaseema Hi-Strength Hypo Limited
Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal. The company provides sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids; purichlor, chloramine, oleum, sodium dichloroisocyanurate, and hydrogen gas; and aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder and solution, and water treatmen
More in Basic Materials
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.